SEC Form 4 · accession 0001209191-16-133866
Clearside Biomedical, Inc. · CLSD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Noronha
Officer — Executive Vice President, R&D
Period of report
Jul 21, 2016
Accepted (ET)
Jul 25, 2016 · 6:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001539029
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $6.49 | Jul 21, 2016 | A | 30,000 | A | — | Jul 20, 2026 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1One-fourth of the shares underlying this option vest on July 21, 2017 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.